Logo image of ADNT

ADIENT PLC (ADNT) Stock Fundamental Analysis

NYSE:ADNT - New York Stock Exchange, Inc. - IE00BD845X29 - Common Stock - Currency: USD

22.41  -0.58 (-2.52%)

Fundamental Rating

3

ADNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. ADNT may be in some trouble as it scores bad on both profitability and health. ADNT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ADNT was profitable.
In the past year ADNT had a positive cash flow from operations.
In multiple years ADNT reported negative net income over the last 5 years.
Each year in the past 5 years ADNT had a positive operating cash flow.
ADNT Yearly Net Income VS EBIT VS OCF VS FCFADNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -3.11%, ADNT is doing worse than 82.50% of the companies in the same industry.
With a Return On Equity value of -16.16%, ADNT is not doing good in the industry: 82.50% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 6.40%, ADNT is doing worse than 70.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ADNT is below the industry average of 9.12%.
The last Return On Invested Capital (6.40%) for ADNT is above the 3 year average (5.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -3.11%
ROE -16.16%
ROIC 6.4%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ADNT Yearly ROA, ROE, ROICADNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

ADNT's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 2.98%, ADNT is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
ADNT's Operating Margin has improved in the last couple of years.
ADNT has a Gross Margin of 6.52%. This is amonst the worse of the industry: ADNT underperforms 93.75% of its industry peers.
In the last couple of years the Gross Margin of ADNT has grown nicely.
Industry RankSector Rank
OM 2.98%
PM (TTM) N/A
GM 6.52%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
ADNT Yearly Profit, Operating, Gross MarginsADNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ADNT is creating some value.
The number of shares outstanding for ADNT has been reduced compared to 1 year ago.
ADNT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ADNT has an improved debt to assets ratio.
ADNT Yearly Shares OutstandingADNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ADNT Yearly Total Debt VS Total AssetsADNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ADNT has an Altman-Z score of 1.86. This is not the best score and indicates that ADNT is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.86, ADNT is doing worse than 78.75% of the companies in the same industry.
The Debt to FCF ratio of ADNT is 10.24, which is on the high side as it means it would take ADNT, 10.24 years of fcf income to pay off all of its debts.
ADNT has a Debt to FCF ratio of 10.24. This is in the lower half of the industry: ADNT underperforms 72.50% of its industry peers.
A Debt/Equity ratio of 1.45 is on the high side and indicates that ADNT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.45, ADNT is doing worse than 88.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.45
Debt/FCF 10.24
Altman-Z 1.86
ROIC/WACC1.16
WACC5.49%
ADNT Yearly LT Debt VS Equity VS FCFADNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

A Current Ratio of 1.11 indicates that ADNT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.11, ADNT is doing worse than 91.25% of the companies in the same industry.
ADNT has a Quick Ratio of 1.11. This is a bad value and indicates that ADNT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ADNT (0.90) is worse than 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.9
ADNT Yearly Current Assets VS Current LiabilitesADNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

ADNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.24%.
The Earnings Per Share has been growing slightly by 2.56% on average over the past years.
ADNT shows a decrease in Revenue. In the last year, the revenue decreased by -5.33%.
Measured over the past years, ADNT shows a decrease in Revenue. The Revenue has been decreasing by -2.33% on average per year.
EPS 1Y (TTM)-16.24%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%27.78%
Revenue 1Y (TTM)-5.33%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%-3.71%

3.2 Future

ADNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.50% yearly.
The Revenue is expected to grow by 1.10% on average over the next years.
EPS Next Y-1.38%
EPS Next 2Y11.43%
EPS Next 3Y26.83%
EPS Next 5Y33.5%
Revenue Next Year-3.79%
Revenue Next 2Y-2.08%
Revenue Next 3Y-0.46%
Revenue Next 5Y1.1%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ADNT Yearly Revenue VS EstimatesADNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
ADNT Yearly EPS VS EstimatesADNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.43 indicates a reasonable valuation of ADNT.
ADNT's Price/Earnings ratio is a bit cheaper when compared to the industry. ADNT is cheaper than 62.50% of the companies in the same industry.
ADNT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.51.
With a Price/Forward Earnings ratio of 9.76, the valuation of ADNT can be described as very reasonable.
The rest of the industry has a similar Price/Forward Earnings ratio as ADNT.
When comparing the Price/Forward Earnings ratio of ADNT to the average of the S&P500 Index (35.58), we can say ADNT is valued rather cheaply.
Industry RankSector Rank
PE 11.43
Fwd PE 9.76
ADNT Price Earnings VS Forward Price EarningsADNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

68.75% of the companies in the same industry are more expensive than ADNT, based on the Enterprise Value to EBITDA ratio.
68.75% of the companies in the same industry are more expensive than ADNT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.05
EV/EBITDA 4.74
ADNT Per share dataADNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

ADNT's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)4.46
EPS Next 2Y11.43%
EPS Next 3Y26.83%

0

5. Dividend

5.1 Amount

ADNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ADIENT PLC

NYSE:ADNT (7/15/2025, 3:40:55 PM)

22.41

-0.58 (-2.52%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-06 2025-08-06/amc
Inst Owners97.63%
Inst Owner Change-0.06%
Ins Owners0.95%
Ins Owner Change2.71%
Market Cap1.88B
Analysts51.25
Price Target17.15 (-23.47%)
Short Float %7.57%
Short Ratio4.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.49%
Min EPS beat(2)39.64%
Max EPS beat(2)101.33%
EPS beat(4)3
Avg EPS beat(4)29.7%
Min EPS beat(4)-49.75%
Max EPS beat(4)101.33%
EPS beat(8)5
Avg EPS beat(8)25.6%
EPS beat(12)7
Avg EPS beat(12)31.37%
EPS beat(16)8
Avg EPS beat(16)-9.81%
Revenue beat(2)1
Avg Revenue beat(2)1.37%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)2.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-4.77%
Max Revenue beat(4)2.79%
Revenue beat(8)3
Avg Revenue beat(8)-0.9%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)6
Avg Revenue beat(16)-0.9%
PT rev (1m)1.89%
PT rev (3m)-17.48%
EPS NQ rev (1m)7.99%
EPS NQ rev (3m)-8.5%
EPS NY rev (1m)2.11%
EPS NY rev (3m)3.28%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)2.1%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)1.14%
Valuation
Industry RankSector Rank
PE 11.43
Fwd PE 9.76
P/S 0.13
P/FCF 8.05
P/OCF 3.88
P/B 1.14
P/tB N/A
EV/EBITDA 4.74
EPS(TTM)1.96
EY8.75%
EPS(NY)2.3
Fwd EY10.25%
FCF(TTM)2.79
FCFY12.43%
OCF(TTM)5.77
OCFY25.76%
SpS171.2
BVpS19.66
TBVpS-5.57
PEG (NY)N/A
PEG (5Y)4.46
Profitability
Industry RankSector Rank
ROA -3.11%
ROE -16.16%
ROCE 8.43%
ROIC 6.4%
ROICexc 7.51%
ROICexgc 14.72%
OM 2.98%
PM (TTM) N/A
GM 6.52%
FCFM 1.63%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ROICexc(3y)6.22%
ROICexc(5y)5.21%
ROICexgc(3y)13.54%
ROICexgc(5y)10.98%
ROCE(3y)6.73%
ROCE(5y)5.58%
ROICexcg growth 3Y4.55%
ROICexcg growth 5Y38.95%
ROICexc growth 3Y0.66%
ROICexc growth 5Y34.59%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
F-Score4
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 1.45
Debt/FCF 10.24
Debt/EBITDA 3.17
Cap/Depr 76.99%
Cap/Sales 1.74%
Interest Coverage 250
Cash Conversion 64.32%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.9
Altman-Z 1.86
F-Score4
WACC5.49%
ROIC/WACC1.16
Cap/Depr(3y)73.03%
Cap/Depr(5y)79.22%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.24%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%27.78%
EPS Next Y-1.38%
EPS Next 2Y11.43%
EPS Next 3Y26.83%
EPS Next 5Y33.5%
Revenue 1Y (TTM)-5.33%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%-3.71%
Revenue Next Year-3.79%
Revenue Next 2Y-2.08%
Revenue Next 3Y-0.46%
Revenue Next 5Y1.1%
EBIT growth 1Y-13.88%
EBIT growth 3Y-5.76%
EBIT growth 5Y30.09%
EBIT Next Year63.86%
EBIT Next 3Y22.46%
EBIT Next 5Y23.5%
FCF growth 1Y15.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.05%
OCF growth 3Y30.56%
OCF growth 5Y12.01%